Yoshimura M, Pekary A E, Pang X P, Berg L, Goodwin T M, Hershman J M
Endocrinology Research Laboratory, West Los Angeles Veterans Affairs Medical Center, California 90073.
J Clin Endocrinol Metab. 1994 Apr;78(4):862-6. doi: 10.1210/jcem.78.4.8157712.
hCG is known to have thyroid-stimulating activity and may cause hyperthyroidism in patients with trophoblastic diseases. hCG occurs in normal and molar pregnancy with breaks or nicks in the alpha- or beta-subunit peptide linkage and with substantial heterogeneity in the composition and degree of branching within the oligosaccharide side-chains. The bioactivity of hCG is markedly influenced by these structural variations. We purified hCG from five hydatidiform moles, using chromatofocusing separation after gel filtration. The hCG molecules were fractionated according to their isoelectric points, with a linear pH gradient from 3.2-6.1 and a final 1.0 mol/L NaCl step elution. The hCG immunoreactivity of each fraction was measured by RIA, and the thyroid-stimulating activity of hCG was determined by means of the cAMP response in Chinese hamster ovary cells expressing functional human TSH receptors (Chinese hamster ovary-JP09 cells). The chromatofocusing profile showed that hCG from the moles was eluted in six or seven major peaks at pH 6.1, 5.5, 5.3, 4.8, 3.8, and 3.2 and with 1.0 mol/L NaCl, whereas hCG extracted from serum of hydatidiform moles and standard hCG preparation CR-127 extracted from pregnancy urine showed only small peaks at pH greater than 5.3. Each fraction increased cAMP production significantly in Chinese hamster ovary-JP09 cells. The relative bioactivity/immunoreactivity, represented as the ratio of cAMP/hCG (picomoles per IU), was significantly higher in basic components (pI 6.1, 6.2 +/- 1.2; pI 5.5, 4.4 +/- 2.7; pI 5.3, 5.8 +/- 0.3) than in hCG CR-127 (bioactivity/immunoreactivity, 0.42; P < 0.05). The difference in pI of each hCG isoform was attributable to the extent of sialylation; basic hCG isoforms contained less sialic acid by immunological detection using lectins. These results indicate that isoforms of hCG with more thyrotropic activity were produced by trophoblastic tissues in patients with hydatidiform mole. We speculate that these isoforms of hCG may be responsible for the hyperthyroidism in some patients with hydatidiform moles.
已知人绒毛膜促性腺激素(hCG)具有刺激甲状腺的活性,可能导致滋养层疾病患者出现甲状腺功能亢进。在正常妊娠和葡萄胎妊娠中,hCG的α或β亚基肽键存在断裂或切口,并且寡糖侧链的组成和分支程度存在显著异质性。这些结构变异对hCG的生物活性有显著影响。我们从5例葡萄胎中纯化hCG,在凝胶过滤后采用层析聚焦分离法。根据hCG分子的等电点进行分级分离,pH梯度为3.2 - 6.1呈线性,最后用1.0 mol/L氯化钠进行一步洗脱。通过放射免疫分析(RIA)测定各馏分的hCG免疫反应性,并通过在中国仓鼠卵巢细胞(表达功能性人促甲状腺激素受体,即中国仓鼠卵巢 - JP09细胞)中的环磷酸腺苷(cAMP)反应来测定hCG的刺激甲状腺活性。层析聚焦图谱显示,来自葡萄胎的hCG在pH 6.1、5.5、5.3、4.8、3.8和3.2以及1.0 mol/L氯化钠条件下以六个或七个主峰洗脱,而从葡萄胎血清中提取的hCG以及从妊娠尿液中提取的标准hCG制剂CR - 127在pH大于5.3时仅显示小峰。每个馏分在中国仓鼠卵巢 - JP09细胞中均显著增加cAMP的产生。以cAMP/hCG(每国际单位皮摩尔数)的比值表示的相对生物活性/免疫反应性在碱性组分(pI 6.1,6.2±1.2;pI 5.5,4.4±2.7;pI 5.3,5.8±0.3)中显著高于hCG CR - 127(生物活性/免疫反应性,0.42;P < 0.05)。每种hCG同工型等电点的差异归因于唾液酸化程度;通过使用凝集素的免疫检测发现,碱性hCG同工型含有的唾液酸较少。这些结果表明,葡萄胎患者的滋养层组织产生了具有更高促甲状腺活性的hCG同工型。我们推测,这些hCG同工型可能是部分葡萄胎患者出现甲状腺功能亢进的原因。